Search Tag: cardiovascular disease
2020 11 May
The rapid global distribution of the Coronavirus and the fear of collapsing healthcare systems have forced hospitals to concentrate on the treatment of COVID-19 patients and allocate their resources accordingly. As a consequence up to 80% of the elective cardiovascular (CV) interventions have been indefinitely postponed.1 This measure resulted in a...Read more
2020 11 May
Summary: Quarantining and public interventions during the COVID-19 pandemic have raised concerns about a decrease in presentations for urgent and life-threatening cardiovascular diseases. Cardiovascular disease may remain undiagnosed for a longer duration. How can this be addressed? Introduction All members of the coronaviruses (CoV)...Read more
2020 06 May
As the healthcare community attempts to deal with the coronavirus disease (COVID-19), there is an intense effort to develop an effective treatment strategy. While research on the development of a vaccine continues, clinicians have been forced to use treatments that lack robust clinical evidence. With many patients succumbing to acute respiratory distress...Read more
2020 26 Mar
Maddalena Lettino of San Gerardo Hospital, Monza (Italy) answers some important questions regarding cardiology patients, cardiac care and COVID-19 in the new series of podcasts by the European Society of Cardiology (ESC). What have we learned from this experience? And what is the situation of the acute cardiology patient in this pandemic situation?...Read more
2020 25 Mar
The world is facing a health crisis. It all started with China but now, Europe accounts for about three quarters of new daily cases. Italy and Spain are in a very difficult situation, and France and Germany are not so far behind. The European Society of Cardiology (ESC) has recently put together a series of practical podcasts from speakers with the...Read more
2020 16 Mar
According to the latest figures from the World Health Organization (WHO) , there are a total of 168,019 confirmed cases of coronavirus worldwide. So far, the virus has caused 6610 deaths and has affected 148 countries. The highest number of cases are in China (81,077), followed by Italy (24,747), Iran (14,991), Republic of Korea (8236), Spain (7753),...Read more
2020 09 Mar
HealthManagement.org rounds up exciting developments that have all the marks of healthcare game changers. What do you think? Advancements in Cardiac Imaging Conventional imaging still remains important for the assessment of cardiac structure and function. However, advanced echocardiography with strain imaging techniques, tissue characterisation...Read more
2020 20 Feb
Despite significant advances in the diagnosis and management of cardiac disease, cardiovascular disease continues to have high morbidity and mortality. In some cases, the diagnosis is delayed, while in others, the diagnosis is mistaken for another disorder. Advanced technology and machine learning have opened up new opportunities to evaluate image-based...Read more
2020 12 Feb
Transcatheter aortic valve replacements are routinely done at many institutions in patients not deemed candidates for open-heart surgery. Over the years, many short term studies have been published on the outcomes of TAVR. Findings from the PARTNER 2 study were published in 2016 and now, PARTNER 2A presents the late outcomes of TAVR. These findings...Read more
2020 12 Feb
Certain classes of anticancer drugs are cardiotoxic, especially the anthracycline group of chemotherapeutic agents. In most cases, the cardiotoxic effect of these agents comes to light when the patient undergoes surgery for cancer and then develops heart failure, arrhythmias or dies. Most oncologists and surgeons make it a point to ensure that patients...Read more
2020 31 Jan
Women have steeper increases in blood pressure than men throughout their life, and cardiovascular disease presents itself much differently in women than men. While biology is an important concept when defining the sex differences in the pathophysiology of cardiovascular disease, its pathophysiologic alterations, and variability in treatment effectiveness,...Read more
2020 27 Jan
Over the years, there has been significant progress in the treatment of children with cancer. This has resulted in an increase in the number of cancer survivors living into adulthood. However, significant impact has been observed on the long-term health of these individuals, with many of them experiencing chronic health issues related to previous treatment....Read more
2020 27 Jan
There is very little evidence that screening tests reduce mortality in asymptomatic individuals. However, clinicians have a strong belief that diagnostic tests can help find disease in its earliest stages. That is why many top-ranking hospitals offer executive screening programmes that are primarily targeted to wealthy individuals who can afford to...Read more
2020 15 Jan
Cardiovascular disease continues to be the leading cause of death worldwide. Over the years, scientific research and technological advancements in heart disease and stroke science have had a positive impact on the diagnosis and treatment of cardiovascular disease. Here is a quick overview of the biggest scientific victories achieved in 2019, as...Read more
2019 27 Dec
As we move into 2020, here's a quick recap of our most clicked stories in Cardiology in 2019: ORION-10 Trial: Inclisiran Effective at Reducing LDL Findings from the ORION-10 trial presented at the AHA Scientific Session in 2019 showed that twice-yearly injections of inclisiran were effective at reducing LDL cholesterol. ENCOURAGE...Read more
2019 16 Dec
A new paper in Family Practice, published by Oxford University Press, found that the widespread use of statins and cancer screening technology may have altered the benefits of aspirin use. Researchers concluded that aspirin no longer provides a net benefit as primary prevention for cardiovascular disease and cancer. Nearly half of adults 70 years...Read more
2019 16 Dec
Middle-income countries shoulder the bulk of morbidity and mortality from cardiovascular disease (CVD) in Europe, according to a major report published today in European Heart Journal. The document details the burden of CVD in the 57 ESC member countries, the infrastructure and human resources available for treatment, and the vast differences...Read more
2019 01 Dec
Aspirin (acetylsalicylic acid) has the unique ability to to irreversibly acetylate serine in the active site of cyclo-oxygenase (COX), permanently blocking its action in prostaglandin synthesis. This results in analgesic, antipyretic, and anti-inflammatory effects. In the platelet, it has a more durable and sustained effect. However, while aspirin...Read more
2019 01 Dec
Insufficient sleep is one reason why disadvantaged groups have more heart disease. That’s the finding of a study published today in Cardiovascular Research, a journal of the European Society of Cardiology (ESC). People with lower socioeconomic status sleep less for a variety of reasons: they may do several jobs, work in shifts, live in noisy environments,...Read more
2019 23 Nov
Statins are an effective medication for treating patients with heart disease. They cut the risk of a second major adverse cardiac event by almost 50$. But only about 6% of patients take statins as prescribed. One way to solve that? Nudge them. Literally. In a new study presented to heart specialists from around the world, researchers at the Intermountain...Read more
2019 14 Nov
There has been extensive literature on the benefits of exercise, including running. Not only does running improve physical endurance, it has been shown to lower body weight, enable better control of blood pressure and blood glucose, improve mental health and lower the risk of adverse cardiac events. However, current literature on how much to run, at...Read more
2019 13 Nov
Prof. Mamas A Mamas is a structural interventional cardiologist, treating patients with underlying coronary artery with percutaneous coronary intervention (PCI) in both the elective and emergency setting and undertaking Transcatheter Aortic Valve Interventions (TAVI). He is also the Associate Editor of Circulation Cardiovascular Interventions...Read more
2019 21 Oct
Familial hypercholesterolaemia is typically characterised by severely elevated low-density lipoprotein (LDL) cholesterol levels and premature cardiovascular disease. While the short-term efficacy of statin therapy in children is well established, there is still a lack of longer follow-up studies to evaluate specific changes in the risk of cardiovascular...Read more
2019 02 Oct
Despite underlying physiological differences and a different set of risk factors, diagnosis, management, and treatment strategies for hypertension do not account for sex and gender variances. Evidence-based guidelines for hypertension treatment from clinical trials are similar between males and females; however, most of these trials do not...Read more
2019 23 Sep
A combination pill containing three medications used to tackle high blood pressure and one used for high cholesterol was found to reduce cardiovascular disease (CVD) risk by 25%. The study, published in the New England Journal of Medicine (NEJM), assessed the effectiveness of atorvastatin, amlodipine, losartan and hydrochlorothiazide in polypill...Read more
2019 29 Aug
ESC Congress is the world’s largest gathering of cardiovascular professionals contributing to global awareness of the latest clinical trials and breakthrough discoveries. ESC Congress 2019 together with the World Congress of Cardiology takes place from 31 August to 4 September at the Expo Porte de Versailles in Paris, France. The ESC Congress...Read more
2019 26 Aug
Arthur M. Feldman, MD, PhD, Laura H. Carnell Professor of Medicine at the Lewis Katz School of Medicine at Temple University, has been recognised with the 2019 Distinguished Scientist Award-Basic Domain by the American College of Cardiology. Prof. Feldman has received this honour due to his contribution towards improving cardiovascular health and...Read more
2019 26 Aug
Summary: Overview about the value of mHealth in cardiology exemplified by some promising tools that for sure will change the way cardiology is practiced, especially in the management of rhythm disturbances like atrial fibrillation. Where Are We Now? Nowadays, there is a lot of hype about the role of wearables and mobile health (mHealth)...Read more